A Randomized Clinical Study on Combination of Concurrent Chemo-Radiotherapy and Thalidomide for Middle-Late Esophageal Cancer

A Randomized Clinical Study on Combination of Concurrent Chemo-Radiotherapy and Thalidomide for Middle-Late Esophageal Cancer

OBJECTIVE To evaluate the response rate and tolerance of patients with middle-late esophageal carcinoma, who were treated with concurrent chemoradiotherapy (CCRT) plus thalidomide. METHODS Sixty-five eligible patients with local middle-late esophageal carcinoma were randomly assigned to the tr...

Full description

Bibliographic Details
Main Authors: Gui-zhi LI, Zu-sheng MA, Ming-jin SHE
Format: Article
Language:English
Published: China Anti-Cancer Association 2010-04-01
Series:Cancer Biology & Medicine
Subjects:
esophageal neoplasm
thalidomide
radiotherapy
drug therapy.
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/145

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/145

Similar Items